Physician profile
Anu Davis
NPI 1023117082
$989.29
in general payments reported to CMS, 2019-2025
15 companies · $202 in 2025
The $202 reported for 2025 was less than what a typical Endocrinology, Diabetes & Metabolism provider received nationally (typical 2025 total: $506).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $70.52 · 2020: $137 · 2021: $156 · 2022: $285 · 2023: $39.10 · 2024: $99.53 · 2025: $202.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $340.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $340.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $242.08 | 2020-2025 | Wegovy |
| Zealand Pharma US, INC. | $163.46 | 2021-2022 | |
| Lilly USA, LLC | $123.55 | 2022 | |
| Corcept Therapeutics | $77.41 | 2025 | Korlym |
| Valeritas, INC. | $70.52 | 2019 | |
| Abbott Laboratories | $69.63 | 2021-2023 | Freestyle Libre |
| Amgen INC. | $47.76 | 2024-2025 | Evenity, Prolia, Repatha |
| Beta Bionics, INC. | $41.21 | 2024-2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Contact Detach, Ilet Insulin Infusion Kit Inset |
| Ibsa Pharma INC. | $33.28 | 2023-2024 | Tirosint, Licart, Tirosint |
| Bayer Healthcare Pharmaceuticals INC. | $32.73 | 2024-2025 | |
| Exact Sciences Corporation | $24.41 | 2025 | Cologuard Collection Kit |
| Genentech USA, INC. | $19.04 | 2020 | |
| Idorsia Pharmaceuticals US INC | $17.17 | 2024 | Quviviq |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $15.68 | 2024 | Trulance, Xifaxan |
| Amneal Pharmaceuticals LLC | $11.36 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anu Davis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.